These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28607438)

  • 21. The 3D structure of the anticancer prodrug CPT-11 with Torpedo californica acetylcholinesterase rationalizes its inhibitory action on AChE and its hydrolysis by butyrylcholinesterase and carboxylesterase.
    Harel M; Hyatt JL; Brumshtein B; Morton CL; Wadkins RM; Silman I; Sussman JL; Potter PM
    Chem Biol Interact; 2005 Dec; 157-158():153-7. PubMed ID: 16289500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of a complex of the potent and specific inhibitor BW284C51 with Torpedo californica acetylcholinesterase.
    Felder CE; Harel M; Silman I; Sussman JL
    Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 2):1765-71. PubMed ID: 12351819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long route or shortcut? A molecular dynamics study of traffic of thiocholine within the active-site gorge of acetylcholinesterase.
    Xu Y; Colletier JP; Weik M; Qin G; Jiang H; Silman I; Sussman JL
    Biophys J; 2010 Dec; 99(12):4003-11. PubMed ID: 21156143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accurate prediction of the bound conformation of galanthamine in the active site of Torpedo californica acetylcholinesterase using molecular docking.
    Pilger C; Bartolucci C; Lamba D; Tropsha A; Fels G
    J Mol Graph Model; 2001; 19(3-4):288-96, 374-8. PubMed ID: 11449566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease.
    Zueva I; Dias J; Lushchekina S; Semenov V; Mukhamedyarov M; Pashirova T; Babaev V; Nachon F; Petrova N; Nurullin L; Zakharova L; Ilyin V; Masson P; Petrov K
    Neuropharmacology; 2019 Sep; 155():131-141. PubMed ID: 31132435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors.
    Alpan AS; Parlar S; Carlino L; Tarikogullari AH; Alptüzün V; Güneş HS
    Bioorg Med Chem; 2013 Sep; 21(17):4928-37. PubMed ID: 23891231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular dynamics of mouse acetylcholinesterase complexed with huperzine A.
    Tara S; Helms V; Straatsma TP; McCammon JA
    Biopolymers; 1999 Oct; 50(4):347-59. PubMed ID: 10423544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal packing mediates enantioselective ligand recognition at the peripheral site of acetylcholinesterase.
    Haviv H; Wong DM; Greenblatt HM; Carlier PR; Pang YP; Silman I; Sussman JL
    J Am Chem Soc; 2005 Aug; 127(31):11029-36. PubMed ID: 16076210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Energy landscapes of human acetylcholinesterase and its Huperzine A-inhibited counterpart.
    Trapp M; Trovaslet M; Nachon F; Koza MM; van Eijck L; Hill F; Weik M; Masson P; Tehei M; Peters J
    J Phys Chem B; 2012 Dec; 116(51):14744-53. PubMed ID: 23186408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood-brain barrier permeable anticholinesterase aurones: synthesis, structure-activity relationship, and drug-like properties.
    Liew KF; Chan KL; Lee CY
    Eur J Med Chem; 2015 Apr; 94():195-210. PubMed ID: 25768702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the binding of cholinesterase inhibitors by docking and molecular dynamics studies.
    Ali MR; Sadoqi M; Møller SG; Boutajangout A; Mezei M
    J Mol Graph Model; 2017 Sep; 76():36-42. PubMed ID: 28711758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new role for the nonpathogenic nonsynonymous single-nucleotide polymorphisms of acetylcholinesterase in the treatment of Alzheimer's disease: a computational study.
    Saravanaraman P; Chinnadurai RK; Boopathy R
    J Comput Biol; 2014 Aug; 21(8):632-47. PubMed ID: 24611490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of Torpedo californica acetylcholinesterase inhibition by bisnorcymserine and crystal structure of the complex with its leaving group.
    Bartolucci C; Stojan J; Yu QS; Greig NH; Lamba D
    Biochem J; 2012 Jun; 444(2):269-77. PubMed ID: 22390827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Affinity binding-guided fluorescent nanobiosensor for acetylcholinesterase inhibitors via distance modulation between the fluorophore and metallic nanoparticle.
    Zhang Y; Hei T; Cai Y; Gao Q; Zhang Q
    Anal Chem; 2012 Mar; 84(6):2830-6. PubMed ID: 22339669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A preliminary comparison of structural models for catalytic intermediates of acetylcholinesterase.
    Silman I; Millard CB; Ordentlich A; Greenblatt HM; Harel M; Barak D; Shafferman A; Sussman JL
    Chem Biol Interact; 1999 May; 119-120():43-52. PubMed ID: 10421437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the acetylcholinesterase active site protonation on omega loop and active site dynamics.
    Wiesner J; Kříž Z; Kuča K; Jun D; Koča J
    J Biomol Struct Dyn; 2010 Dec; 28(3):393-403. PubMed ID: 20919754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular docking study on the "back door" hypothesis for product clearance in acetylcholinesterase.
    Alisaraie L; Fels G
    J Mol Model; 2006 Feb; 12(3):348-54. PubMed ID: 16341717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structure of thioflavin T bound to the peripheral site of Torpedo californica acetylcholinesterase reveals how thioflavin T acts as a sensitive fluorescent reporter of ligand binding to the acylation site.
    Harel M; Sonoda LK; Silman I; Sussman JL; Rosenberry TL
    J Am Chem Soc; 2008 Jun; 130(25):7856-61. PubMed ID: 18512913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational flexibility in the peripheral site of Torpedo californica acetylcholinesterase revealed by the complex structure with a bifunctional inhibitor.
    Colletier JP; Sanson B; Nachon F; Gabellieri E; Fattorusso C; Campiani G; Weik M
    J Am Chem Soc; 2006 Apr; 128(14):4526-7. PubMed ID: 16594661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional structures of Drosophila melanogaster acetylcholinesterase and of its complexes with two potent inhibitors.
    Harel M; Kryger G; Rosenberry TL; Mallender WD; Lewis T; Fletcher RJ; Guss JM; Silman I; Sussman JL
    Protein Sci; 2000 Jun; 9(6):1063-72. PubMed ID: 10892800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.